- Home
- NYT vs PEN Comparison
NYT vs PEN Comparison
Compare NYT & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NYT
- PEN
- Stock Information
- Founded
- NYT 1851
- PEN 2004
- Country
- NYT United States
- PEN United States
- Employees
- NYT N/A
- PEN N/A
- Industry
- NYT Newspapers/Magazines
- PEN Medical/Dental Instruments
- Sector
- NYT Consumer Discretionary
- PEN Health Care
- Exchange
- NYT Nasdaq
- PEN Nasdaq
- Market Cap
- NYT 9.3B
- PEN 9.0B
- IPO Year
- NYT N/A
- PEN 2015
- Fundamental
- Price
- NYT $57.49
- PEN $240.60
- Analyst Decision
- NYT Buy
- PEN Strong Buy
- Analyst Count
- NYT 6
- PEN 16
- Target Price
- NYT $60.33
- PEN $300.47
- AVG Volume (30 Days)
- NYT 2.3M
- PEN 519.1K
- Earning Date
- NYT 08-06-2025
- PEN 07-29-2025
- Dividend Yield
- NYT 1.25%
- PEN N/A
- EPS Growth
- NYT 19.25
- PEN 915.21
- EPS
- NYT 1.93
- PEN 3.74
- Revenue
- NYT $2,661,490,000.00
- PEN $1,280,152,000.00
- Revenue This Year
- NYT $8.91
- PEN $14.60
- Revenue Next Year
- NYT $5.96
- PEN $14.24
- P/E Ratio
- NYT $29.77
- PEN $64.39
- Revenue Growth
- NYT 7.88
- PEN 12.92
- 52 Week Low
- NYT $44.83
- PEN $164.42
- 52 Week High
- NYT $62.24
- PEN $310.00
- Technical
- Relative Strength Index (RSI)
- NYT 58.87
- PEN 48.46
- Support Level
- NYT $51.03
- PEN $234.34
- Resistance Level
- NYT $62.24
- PEN $242.33
- Average True Range (ATR)
- NYT 1.55
- PEN 6.95
- MACD
- NYT 0.74
- PEN 1.43
- Stochastic Oscillator
- NYT 57.63
- PEN 41.62
About NYT New York Times Company (The)
New York Times Co is an American media company known for publishing its flagship newspaper, The New York Times. The company also operates the International New York Times newspaper, as well as digital properties such as NYTimes and various smartphone applications. The company has two segments: New York Times Group and The Athletic. The company generates the majority of its revenue from the NYTG segment. The NYTG and The Athletic segments derive revenue from subscriptions, Advertising, and others, where the majority source of revenue for both segments is subscription.
About PEN Penumbra Inc.
Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. It operates as one reportable segment and its business activity consists of the design, development, manufacturing and marketing of inventive medical products.